This website uses non-intrusive cookies to improve your user experience. You can visit our cookie privacy page for more information.

Active substance approvals and re-registration requirements: June 2015

Regulatory Update 09/2015
Issued:15th July 2015

Updating your authorisation

Please note that HSE does not directly notify product authorisation holders where a change or update of current authorisation is required because of change by the EC to an approval of an active substance.

Authorisation holders have an obligation under Regulation (EC) 1107/2009 to renew their registration (relevant to substances falling under Article 80 transitional measures of the Regulation). Details of how to do this are given on the post-inclusion deadline and re-registration page of our website.

Active substance approvals

At the Standing Committee on Plants, Animals, Food and Feed (SCoPAFF) on 29 May 2015 it was agreed to approve under Regulation (EC) 1107/2009:

Lecithins, Salix cortex, vinegar approvals

These substances were approved as a basic substance for an unlimited period according to the criteria under Article 23 of Regulation (EC) 1107/2009.

Fenhexamid, pyridate, sulfosulfuron, ferric phosphate approvals

These substances were considered under the second stage of the renewal programme (governed by Commission Regulation 1141/2010). Also, authorisations for products containing these substances will need to be renewed in accordance with Article 43 of Regulation (EC) 1107/2009. Further information on renewing authorisations will be published on CRD's website in due course.

Ferric phosphate was also approved as a low risk substance, meeting the criteria established for this at point 5, Annex II of Regulation (EC) 1107/2009.

Other information

When various draft documents are published (eg data lists, review reports and approval regulations) we will update the 'table of recent deadlines' (for substances with extant CRD step 2 re-registration deadlines) if required. You should check this table on a regular basis to determine if, for example, lists of protected studies are now available. Also, please note amendments made to the conditions of approval, review reports or endpoints of the following substances:

Lambda-cyhalothrin

The following amended tox endpoints have been noted for this active substance:

ADI 0.0025 mg/kg bw per day

AOEL 0.00063 mg/kg bw per day

ARfD 0.005 mg/kg bw

Contact Details

If you have any questions relating to this Regulatory Update, please contact us: Link to Contact details page

Resources

Updated 2017-09-07